Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$700K Sell
1,933
-4
-0.2% -$1.37K 0.13% 147
2026
Q1
$681K Sell
1,937
-380
-16% -$135K 0.14% 147
2025
Q4
$758K Sell
2,317
-48
-2% -$15.2K 0.16% 134
2025
Q3
$668K Buy
2,365
+240
+11% +$69.6K 0.15% 139
2025
Q2
$593K Buy
2,125
+87
+4% +$24.6K 0.15% 132
2025
Q1
$635K Buy
2,038
+244
+14% +$72.1K 0.17% 126
2024
Q4
$467K Buy
1,794
+220
+14% +$65.3K 0.12% 143
2024
Q3
$507K Sell
1,574
-205
-12% -$67.1K 0.14% 136
2024
Q2
$556K Buy
1,779
+87
+5% +$25.6K 0.17% 120
2024
Q1
$481K Sell
1,692
-17
-1% -$4.97K 0.15% 130
2023
Q4
$492K Sell
1,709
-406
-19% -$111K 0.18% 117
2023
Q3
$568K Buy
2,115
+96
+5% +$24K 0.23% 98
2023
Q2
$448K Buy
2,019
+414
+26% +$96.1K 0.18% 118
2023
Q1
$388K Buy
1,605
+235
+17% +$57.7K 0.16% 120
2022
Q4
$360K Sell
1,370
-436
-24% -$117K 0.16% 127
2022
Q3
$407K Buy
1,806
+210
+13% +$50.9K 0.21% 107
2022
Q2
$388K Sell
1,596
-10
-0.6% -$2.45K 0.18% 113
2022
Q1
$388K Buy
1,606
+89
+6% +$20.4K 0.16% 117
2021
Q4
$341K Buy
1,517
+214
+16% +$45.2K 0.16% 118
2021
Q3
$277K Buy
1,303
+331
+34% +$76.2K 0.14% 128
2021
Q2
$237K Hold
972
0.12% 134
2021
Q1
$242K Buy
972
+19
+2% +$4.53K 0.14% 119
2020
Q4
$219K Buy
953
+37
+4% +$8.53K 0.14% 114
2020
Q3
$233K Buy
916
+9
+1% +$2.23K 0.16% 105
2020
Q2
$214K Sell
907
-179
-16% -$40.8K 0.15% 101
2020
Q1
$220K Sell
1,086
-44
-4% -$9.61K 0.17% 102
2019
Q4
$272K Buy
+1,130
New +$249K 0.16% 116

Other funds holding AMGN

Lantz Financial's AMGN Position: Q2 2026 in Review

Lantz Financial reduced its Amgen (AMGN) stake by 0.21% in Q2 2026, selling an estimated $1.37K and leaving 1,933 shares worth $700K. The position accounts for 0.13% of the portfolio, ranked #147.

Lantz Financial first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $758K in Q4 2025. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Lantz Financial held 1,933 shares of Amgen worth $700K as of Q2 2026.
  • Lantz Financial sold 4 Amgen shares in Q2 2026, an estimated $1.37K.
  • Amgen made up 0.13% of Lantz Financial's portfolio in Q2 2026, its #147 holding.
  • Lantz Financial first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • Lantz Financial's Amgen position peaked at $758K in Q4 2025.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Lantz Financial's 13F filing for Q2 2026, filed 9 Jul 2026.